(BAH) Booz Allen Hamilton Holding - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0995021062

AI Solutions, Cyber Solutions, Cloud Migration, Quantum Sciences

BAH EPS (Earnings per Share)

EPS (Earnings per Share) of BAH over the last years for every Quarter: "2020-09": 1.03, "2020-12": 1.04, "2021-03": 0.89, "2021-06": 1.07, "2021-09": 1.26, "2021-12": 1.02, "2022-03": 0.86, "2022-06": 1.13, "2022-09": 1.34, "2022-12": 1.07, "2023-03": 1.01, "2023-06": 1.47, "2023-09": 1.29, "2023-12": 1.41, "2024-03": 1.33, "2024-06": 1.38, "2024-09": 1.81, "2024-12": 1.55, "2025-03": 1.61, "2025-06": 1.48, "2025-09": 0,

BAH Revenue

Revenue of BAH over the last years for every Quarter: 2020-09: 2019.185, 2020-12: 1904.02, 2021-03: 1979.28, 2021-06: 1989.066, 2021-09: 2106.038, 2021-12: 2030.52, 2022-03: 2238.076, 2022-06: 2249.6, 2022-09: 2298.976, 2022-12: 2277.074, 2023-03: 2433.261, 2023-06: 2654.486, 2023-09: 2666.282, 2023-12: 2569.801, 2024-03: 2771.327, 2024-06: 2941.797, 2024-09: 3146.386, 2024-12: 2917.19, 2025-03: 2974.627, 2025-06: 2924, 2025-09: 2890,

Description: BAH Booz Allen Hamilton Holding October 30, 2025

Booz Allen Hamilton Holding Corporation (NYSE: BAH) is a veteran technology and consulting firm that delivers AI-driven, cyber, and cloud-enabled solutions to U.S. cabinet-level agencies and commercial clients worldwide. Its portfolio spans purpose-built artificial-intelligence applications, cyber-defense services, legacy-system modernization, multi-modal data-fusion for ISR and battle-management, as well as emerging quantum information sciences-including quantum computing, sensing, communications, and post-quantum cryptography.

Key operating metrics highlight the firm’s scale and growth trajectory: FY 2023 revenue topped $8.1 billion, with a backlog exceeding $10 billion, indicating strong forward-order flow. AI-related services grew roughly 15 % year-over-year, outpacing the broader IT-consulting sector, while federal IT spending is projected to rise 4-5 % annually through 2028, providing a tailwind for BAH’s government contracts. Additionally, the company’s quantum-technology unit, launched in 2022, has already secured three multi-year DoD research agreements, positioning it to capture early market share as post-quantum standards evolve.

If you’re looking for a data-driven, quantitative assessment of BAH’s valuation, a quick dive into ValueRay’s analytics platform could provide the deeper insight you need.

BAH Stock Overview

Market Cap in USD 12,361m
Sub-Industry IT Consulting & Other Services
IPO / Inception 2010-11-17

BAH Stock Ratings

Growth Rating -28.3%
Fundamental 79.2%
Dividend Rating 67.5%
Return 12m vs S&P 500 -59.9%
Analyst Rating 3.50 of 5

BAH Dividends

Dividend Yield 12m 2.48%
Yield on Cost 5y 2.90%
Annual Growth 5y 13.25%
Payout Consistency 88.3%
Payout Ratio 33.5%

BAH Growth Ratios

Growth Correlation 3m -88.1%
Growth Correlation 12m -83.2%
Growth Correlation 5y 80.9%
CAGR 5y -5.05%
CAGR/Max DD 3y (Calmar Ratio) -0.09
CAGR/Mean DD 3y (Pain Ratio) -0.32
Sharpe Ratio 12m -0.29
Alpha -61.99
Beta 0.414
Volatility 56.18%
Current Volume 3464.1k
Average Volume 20d 1727.5k
Stop Loss 83.1 (-4.7%)
Signal 0.33

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (823.7m TTM) > 0 and > 6% of Revenue (6% = 702.3m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA -1.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 11.85% (prev 9.12%; Δ 2.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.13 (>3.0%) and CFO 909.8m > Net Income 823.7m (YES >=105%, WARN >=100%)
Net Debt (-532.0m) to EBITDA (1.19b) ratio: -0.45 <= 3.0 (WARN <= 3.5)
Current Ratio 1.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (123.2m) change vs 12m ago -4.35% (target <= -2.0% for YES)
Gross Margin 53.45% (prev 54.77%; Δ -1.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 166.9% (prev 166.2%; Δ 0.69pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 5.31 (EBITDA TTM 1.19b / Interest Expense TTM 193.9m) >= 6 (WARN >= 3)

Altman Z'' 4.37

(A) 0.19 = (Total Current Assets 3.22b - Total Current Liabilities 1.83b) / Total Assets 7.15b
(B) 0.47 = Retained Earnings (Balance) 3.38b / Total Assets 7.15b
(C) 0.15 = EBIT TTM 1.03b / Avg Total Assets 7.02b
(D) 0.54 = Book Value of Equity 3.35b / Total Liabilities 6.16b
Total Rating: 4.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.16

1. Piotroski 6.0pt = 1.0
2. FCF Yield 6.92% = 3.46
3. FCF Margin 7.00% = 1.75
4. Debt/Equity 0.29 = 2.46
5. Debt/Ebitda -0.45 = 2.50
6. ROIC - WACC (= 8.19)% = 10.23
7. RoE 77.09% = 2.50
8. Rev. Trend 83.53% = 6.26
9. EPS Trend -20.19% = -1.01

What is the price of BAH shares?

As of November 03, 2025, the stock is trading at USD 87.16 with a total of 3,464,099 shares traded.
Over the past week, the price has changed by +0.73%, over one month by -15.47%, over three months by -21.39% and over the past year by -51.39%.

Is Booz Allen Hamilton Holding a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Booz Allen Hamilton Holding (NYSE:BAH) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 79.16 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BAH is around 64.71 USD . This means that BAH is currently overvalued and has a potential downside of -25.76%.

Is BAH a buy, sell or hold?

Booz Allen Hamilton Holding has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold BAH.
  • Strong Buy: 4
  • Buy: 1
  • Hold: 7
  • Sell: 2
  • Strong Sell: 0

What are the forecasts/targets for the BAH price?

Issuer Target Up/Down from current
Wallstreet Target Price 124.2 42.5%
Analysts Target Price 124.2 42.5%
ValueRay Target Price 71.6 -17.8%

BAH Fundamental Data Overview October 25, 2025

Market Cap USD = 12.36b (12.36b USD * 1.0 USD.USD)
P/E Trailing = 12.3206
P/E Forward = 16.5289
P/S = 1.0333
P/B = 11.9326
P/EG = 2.29
Beta = 0.414
Revenue TTM = 11.71b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.19b USD
Long Term Debt = 3.92b USD (from longTermDebt, last fiscal year)
Short Term Debt = 124.0m USD (from shortTermDebt, last quarter)
Debt = 284.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -532.0m USD (from netDebt column, last quarter)
Enterprise Value = 11.83b USD (12.36b + Debt 284.0m - CCE 816.0m)
Interest Coverage Ratio = 5.31 (Ebit TTM 1.03b / Interest Expense TTM 193.9m)
FCF Yield = 6.92% (FCF TTM 819.0m / Enterprise Value 11.83b)
FCF Margin = 7.00% (FCF TTM 819.0m / Revenue TTM 11.71b)
Net Margin = 7.04% (Net Income TTM 823.7m / Revenue TTM 11.71b)
Gross Margin = 53.45% ((Revenue TTM 11.71b - Cost of Revenue TTM 5.45b) / Revenue TTM)
Gross Margin QoQ = 53.63% (prev 51.33%)
Tobins Q-Ratio = 1.65 (Enterprise Value 11.83b / Total Assets 7.15b)
Interest Expense / Debt = 16.90% (Interest Expense 48.0m / Debt 284.0m)
Taxrate = 24.89% (58.0m / 233.0m)
NOPAT = 772.5m (EBIT 1.03b * (1 - 24.89%))
Current Ratio = 1.76 (Total Current Assets 3.22b / Total Current Liabilities 1.83b)
Debt / Equity = 0.29 (Debt 284.0m / totalStockholderEquity, last quarter 996.0m)
Debt / EBITDA = -0.45 (Net Debt -532.0m / EBITDA 1.19b)
Debt / FCF = -0.65 (Net Debt -532.0m / FCF TTM 819.0m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.51% (Net Income 823.7m / Total Assets 7.15b)
RoE = 77.09% (Net Income TTM 823.7m / Total Stockholder Equity 1.07b)
RoCE = 20.64% (EBIT 1.03b / Capital Employed (Equity 1.07b + L.T.Debt 3.92b))
RoIC = 15.84% (NOPAT 772.5m / Invested Capital 4.88b)
WACC = 7.66% (E(12.36b)/V(12.64b) * Re(7.54%) + D(284.0m)/V(12.64b) * Rd(16.90%) * (1-Tc(0.25)))
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF Debug] Terminal Value 76.27% ; FCFE base≈860.0m ; Y1≈757.0m ; Y5≈622.2m
Fair Price DCF = 91.66 (DCF Value 11.30b / Shares Outstanding 123.2m; 5y FCF grow -14.70% → 3.0% )
EPS Correlation: -20.19 | EPS CAGR: -54.41% | SUE: -4.0 | # QB: 0
Revenue Correlation: 83.53 | Revenue CAGR: 9.05% | SUE: -1.16 | # QB: 0

Additional Sources for BAH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle